UAE-backed biotech company trials drug designed by artificial intelligence – The National

UAE-backed biotech company trials drug designed by artificial intelligence – The National

A UAE-backed biotechnology company has begun testing a drug “discovered and designed” using artificial intelligence on patients.

Insilico Medicine, which is based in Hong Kong and has a research and development centre in Abu Dhabi, harnessed advanced technology to develop a drug to treat idiopathic pulmonary fibrosis, a chronic lung disease which leads to lungs becoming scarred and breathing difficulties.

It said it had completed the first dose in patients this week, as part of Phase II trials, with plans to recruit 60 more people to take part in the study at sites in the US and China.